Longeveron (LGVN) announced that the company’s Board of Directors has appointed Stephen Willard as CEO, effective February 11. He succeeds Than Powell who served as interim CEO prior to the Board’s appointment of Willard as permanent CEO. Powell will support the leadership transition and continue his work in the company’s on-going business development activities. Willard was previously CEO of Icapath, CEO of NRx Pharmaceuticals, CEO of Cellphire, and CEO of Flamel Technologies.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGVN: